Objective: To systematically review the literature on factors associated with a clinical diagnosis of depression or symptoms of depression (depression) among head and neck cancer (HNC) patients.
The prevalence of depression (clinical diagnosis or symptoms of depression) among head and neck cancer (HNC) patients is high and depends on type of measurement (diagnostic interview or patientreported outcome measures [PROMs] ) and time of assessment. 1 Over time, prevalence rates have been reported to vary from 13% to 40% at diagnosis, to 25% to 52% during treatment, to 11% to 45% in the first 6 months following treatment, and seem to decrease in the longer term (9%-27%). 2 The high prevalence at diagnosis and shortly after treatment might be due to HNC-specific symptoms, such as oral dysfunction and difficulties with speaking, eating, or swallowing, and facial disfigurement. [2] [3] [4] [5] [6] Besides HNC-specific symptoms, general cancer-related symptoms 
| Search strategy
A first literature search was conducted in PubMed (May 9, 2017) and in PsycINFO and CINAHL (February 9, 2018) using keywords, MeSH terms, and subject headings. As an update was warranted a search update of all three databases was performed up to August 20, 2018 .
The main keywords were as follows: "head and neck neoplasms,"
"depression," "depressive disorder," "distress," "depressive symptoms,"
"associat*," and "correlat*" (Appendix A). Reference lists of the included studies were searched for additional studies.
| Eligibility criteria
Studies were included if they (1) included a group of adult (greater than or equal to 18 years) HNC patients, (2) had depression as outcome, (3) reported on factors associated with depression at a single (later) time point (prospective analyses) or factors associated with the course of depression (longitudinal analyses), (4) were of a prospective (factors investigated in relation to depression were measured at an earlier time point than the measurement of depression) or longitudinal nature, and (5) full text was available in English. We excluded cross-sectional studies, randomized controlled trials, reviews, and case reports.
| Selection process and quality assessment
After eliminating duplicate studies, article title and abstract were screened by two reviewers (LK or BH and FJ) on eligibility and were either marked for further evaluation or excluded. In the second phase, the full text of the potentially relevant articles were assessed for eligibility based on the eligibility criteria. Disagreement between reviewers was resolved by consensus in each phase. If disagreement was unresolved, a third reviewer was consulted (IV).
Included studies were subjected to a quality assessment using a 12-item quality assessment scoring list (Appendix B). This list was adapted from Hayden et al 7 and has been used in previous studies. 8, 9 The quality assessment comprised four aspects: study population, study attrition, data collection, and data analysis. All items were scored positive (score "1") or negative (score "0"). In case the necessary information was not provided or was unclear, also a negative score was provided. Two reviewers (LK or BH and FJ) independently performed the quality assessments. In case of disagreement between the two reviewers, a third reviewer (IV) was consulted. A total score per study was calculated by summing the scores resulting in a score of 0 to 12.
Studies scoring greater than or equal to 70% of points were categorized "high methodological quality." Studies scoring less than 70%
were categorized "low methodological quality." 9 
| Data extraction
The reviewers (LK or BH and FJ) extracted the following data: author, publication year, number of patients included, HNC sublocation, instrument used to measure depression, and factors investigated in relation to depression. If both univariate and multivariate analyses were used, the multivariate data were collected, since multivariate results are more likely to contain independent factors (factors that are still significant after correcting for potential confounding factors).
| Level of scientific evidence
We used a best-evidence synthesis to categorize the level of evidence of factors associated with (the course of) depression, as used in previous studies. 9, 10 The levels of evidence were (1) strong if a factor was consistently supported by at least two high quality studies, (2) moderate if a factor was consistently supported by at least one high-quality study and at least one low-quality study or if a factor was consistently supported by at least two low-quality studies, and (3) inconclusive, if a factor was supported by only one study or results were inconsistent in multiple studies. A result was defined as consistent if greater than or equal to 75% of studies reported results into the same direction.
3 | RESULTS
| Identification and selection of the literature
The first literature search of PubMed, PsycINFO, and CINAHL yielded 1086 nonduplicate studies ( Figure 1 ). A search update was performed up to August 20, 2018, which yielded 115 additional studies. All of these studies (n = 1201) were first screened based on title and abstract, of which 164 studies were selected for the full-text phase.
In total 33 of these articles fulfilled the eligibility criteria. In addition, two studies were included after screening the reference lists, resulting in 35 articles. These 35 articles provided results on 27 separate studies.
In Table 1 , the characteristics of the 35 included studies are described. Twenty-one studies reported on factors associated with depression at a single time point, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [42] [43] [44] 10 studies on factors associated with the course of depression 33-41,45 and four on both.
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Results on factors associated with depression at a single time point and the course of depression are presented separately. Table 2 ). The only factor that was found to be significantly associated with depression was symptoms of depression at an earlier time point. Seven of the eight studies, which investigated this association, found that symptoms of depression measured before start of treatment, 12, [14] [15] [16] 25 1 month after the end of treatment 20 or at least 1 month after the end of treatment 22 were significantly associated with a higher level of depression at a later time point. The only study that did not found a significant association was Aarstad et al 11 which investigated the association between symptoms of depression at time of hospitalization and depression at on average 6-year follow-up. As two studies were of high methodological quality, 16 ,22 the evidence on this association was rated as strong.
For all other 68 factors, inconsistent evidence was reported.
However, based on at least two high-quality studies, 16, 18, 22, 24, 26, 27, 44 the evidence suggests that age, marital status, education level, ethnicity, treating hospital/region, and poor sleep are not important factors in relation to depression. Also, smoking history, alcohol use, (previous) surgery, type of treatment, tumor location, and cancer recurrence are hypothesized to be unimportant factors in relation to depression, because on all of these factors at least one high-quality study showed no significant association 16, 22, 27, 43 or at least two low-quality studies showed no significant association. 12, 15, 17, 19, 23, 25, 28, 32 For 36 of the other 56 inconsistent factors, evidence was rated as inconsistent as only one study investigated this association. Of the remaining 20 factors, four factors were sociodemographic characteristics. One was a lifestyle characteristic; five factors were clinical characteristics, and 10 were PROMs. On the sociodemographic factors: gender, living alone, and income, some studies showed significantly higher depression among females, [14] [15] [16] 24, 27, 43 people who are living alone, 12 or people with a lower income, 43 while other mo, month(s); N, total number of studies; N+, total number of studies that found a positive association, N-, total number of studies that found a negative association; N0, total number of studies that found no association; post, posttreatment; TNFα, tumor necrosis factor alpha; w, week(s); y, year(s). was not significantly associated with depression, as these two studies were performed in the same study population. 15, 16 To provide further insight into the 56 factors with rating "inconsistent," an overview was created in which we stratified for time period: less than or equal to 3 months (short), 3 to 12 months (medium), and greater than 12 months after treatment (long) (Appendix C).
| Factors associated with the course of depression
From the 14 studies on the course of depression, 39 factors were extracted, of which seven sociodemographic, two lifestyles, 12 clinical factors, 14 PROMs, and four inflammatory markers (Table 3) . On all Note. In bold the results of the studies on factors associated with clinical depression.
Abbreviations: N, total number of studies; N+, total number of studies that found a positive association, N-, total number of studies that found a negative association; N0, total number of studies that found no association; LoE, level of evidence; Assoc, association; HNC, head and neck cancer; TNFα, tumor necrosis factor alpha; IL6, interleukin 6; IFNγ, interferon gamma.
Studies on clinical depression are presented in bold. 
| Study limitations
An important limitation is that vote counting was used to summarize the findings of the included studies. The absence of a significant association may, however, be the consequence of limited power and may not represent an actual absence of an association. In order to provide more clear insight into the association of factors and depression metaanalyses should be performed (eg, regarding HNC-specific symptoms).
We did not perform meta-analyses in this study, as we aimed to provide an overview on all factors investigated in relation to depression and we did not aim to focus on a specific association. Other limitations were the small proportion of studies with high methodological quality (eg, the majority had a sample size less than 100, did not report the baseline participation rate, and performed only univariate analyses).
Also, heterogeneity regarding HNC sublocation measures used to assess depression (eg, CES-D, HADS-D, and BDI), time point of measuring depression, definition of depression (symptoms of depression or a clinical depression) and investigated factors, and the focus on studies, which were written in English limited our study. Finally, we included studies that investigated factors associated with depression regardless of their depression status at time of HNC diagnosis. Further research is warranted that take these limitations into account.
| Clinical implications
The study provides insight into factors associated with depression in HNC patients. In further research, a model can be built that predicts the prognosis of depression and may help improve decision making for the management of depression in HNC patients. A major strength is that only prospective and longitudinal studies were included, while cross-sectional studies were excluded. By these studies, clearer hypotheses can be generated regarding potential causal relationships between factors and depression. Study population and participation The sampling frame and recruitment are adequately described (setting and geographical location) 
